Q&A

Latest News

Petros Levounis
Addiction’s Seat at the Table: An Interview With Outgoing APA President

May 6th 2024

Petros Levounis, MD, MA, talks addiction, buprenorphine, his year as president of the APA, and more at the 2024 Annual Meeting.

What does the recent FDA clearance of this treatment for adolescents mean for the future of MDD treatment?
NeuroStar TMS and the Future of MDD Treatment for Adolescents

April 18th 2024

What are the most effective approaches to SUD treatment in this unique patient population?
SUDs in Women and the Importance of Tailored Treatment Approaches

April 17th 2024

Rosine Perelberg, PhD, discusses psychoanalytic thought, social anthropology, and the future of psychoanalysis.
In Conversation With a Sigourney Award Winner: The Intersection Between Psychoanalytic Thought and Social Anthropology

April 15th 2024

digital therapeutic
Rejoyn: A Fundamental Change in How Clinicians Can Treat MDD Symptoms

April 11th 2024

More News

© 2024 MJH Life Sciences

All rights reserved.